Following the cancellation of the previous classification in 2007, the historical classification of the crus bourgeois du Médoc had been replaced by a simple label issued annually.
The new classification is a return to tradition: now valid for 5 years (from the 2018 vintage to the 2022 vintage), it once again distinguishes the crus bourgeois according to a 3-level hierarchy.
While we can only welcome this new classification, which is more permanent and more legible for consumers, we nevertheless regret that many distinguished Médoc growths did not wish to be part of it (Sociando-Mallet, Gloria, Ormes de Pez, Haut-Marbuzet, Poujeaux, Chasse-Spleen...). But perhaps they will be there in 2025... ?
Neal Martin published his tasting notes for the 2018 Primeurs at the end of the year.
Exceptionally late, this tasting is all the more instructive as it is wines matured by more than 6 months in barrels, therefore closer to the final product, that have been judged.
Like all other tasters before him, Neal Martin praises the quality of the 2018 vintage in Bordeaux, from "very good to excellent", even if he places it after 2016, 2010 and 2005.
As every year, several castles have changed hands. Surprisingly, in 2019, the main transactions will concern the southern Medoc crus:
- Ch. Dauzac (5th grand cru classé de Margaux) bought at the beginning of the year by the Roulleau family (cleaning company SAMSIC),
- Ch. Cambon La Pelouse (Haut-Médoc) bought by an Australian wine giant, TREASURY WINE ESTATE,
- Ch. La Tour de Mons (Margaux) bought by the Perrodo family (Ch. Labégorce, Ch. Marquis d'Alesme),
- Ch. Lamothe-Bergeron (Haut-Médoc) purchased at the end of November by the CAPSSA provident fund,
- Ch. Cantenac-Brown (3rd grand cru classé de Margaux) has just been bought by the LE LOUS family (URGO bandages).